Nebulized antibiotic to prevent pneumonia in children on ventilators
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether giving a nebulized (inhaled) antibiotic called colistimethate sodium can prevent ventilator-associated pneumonia (a lung infection) in children who are on a breathing machine. If it works, this could reduce the risk of serious lung infections in hospitalized children.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 1 month and 14 years old.
- Your child must have been on a breathing machine (ventilator) for more than 48 hours.
- Your child must not already have pneumonia at the start of the study.
- Your child must not have a tracheostomy (a tube placed directly into the windpipe through the neck).
- Your child must not be allergic to colistin (the study drug).
- You must give your permission for your child to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving probiotics (good bacteria) can help prevent pneumonia in children who are on a breathing machine in the intensive care unit. If your child is on a ventilator, these friendly bacteria might help keep their lungs healthy.
This trial tests whether an inhaled antibiotic (amikacin) can help clear a lung infection called ventilator-associated tracheobronchitis in patients who are on a breathing machine. It may reduce infection and improve recovery.
This trial tests an “antibiotic stewardship” approach—choosing and adjusting antibiotics in a smarter way—for a first episode of pneumonia in patients on a breathing machine. It may help ensure the right antibiotics are used at the right time, while avoiding unnecessary or overly broad treatment.
This trial tests if inhaling a medication called colistin can prevent ventilator-associated pneumonia (a lung infection) in patients who are on a breathing machine. It aims to reduce the risk for those at high risk of getting an infection from drug-resistant bacteria.
This trial tests whether giving an inhaled antibiotic called colistin can prevent pneumonia in patients with brain injuries who are on ventilators. If effective, it could reduce lung infections and improve recovery.
This study tests whether adding an inhaled antibiotic (polymyxin) to standard IV antibiotics helps treat a severe lung infection that is resistant to many drugs. It is for people who had a stroke and developed this infection while on a breathing machine. The inhaled drug is delivered directly to the lungs, which might improve treatment and reduce side effects.
Hear when a new Ventilator Associated Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.